Published in Inflammopharmacology on May 30, 2013
Pain management in ambulatory surgery-a review. Pharmaceuticals (Basel) (2014) 0.87
Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates. Ital J Pediatr (2014) 0.86
NQO2 is a reactive oxygen species generating off-target for acetaminophen. Mol Pharm (2014) 0.83
From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain. Soc Cogn Affect Neurosci (2016) 0.82
Comparative metabolomics of muscle interstitium fluid in human trapezius myalgia: an in vivo microdialysis study. Eur J Appl Physiol (2013) 0.81
PANSAID - PAracetamol and NSAID in combination: study protocol for a randomised trial. Trials (2017) 0.80
Safety issues of current analgesics: an update. Clujul Med (2015) 0.80
Over-the-Counter Relief From Pains and Pleasures Alike: Acetaminophen Blunts Evaluation Sensitivity to Both Negative and Positive Stimuli. Psychol Sci (2015) 0.79
The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial. Drug Des Devel Ther (2015) 0.79
PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics (2015) 0.78
AtomicChargeCalculator: interactive web-based calculation of atomic charges in large biomolecular complexes and drug-like molecules. J Cheminform (2015) 0.78
Comparison of clinical efficacy of intravenous acetaminophen with intravenous morphine in acute renal colic: a randomized, double-blind, controlled trial. Emerg Med Int (2014) 0.78
Preventive effect of intrathecal paracetamol on spinal cord injury in rats. Iran Red Crescent Med J (2014) 0.77
A combinational effect of acetaminophen and oriental herbs on the regulation of inflammatory mediators in microglia cell line, BV2. Anat Cell Biol (2015) 0.77
"Carrying Ibuprofen in the Bag": Priority Health Concerns of Latin American Migrants in Spain- A Participatory Qualitative Study. PLoS One (2015) 0.77
Systemic differences in serum metabolome: a cross sectional comparison of women with localised and widespread pain and controls. Sci Rep (2015) 0.76
Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1. PLoS One (2014) 0.75
Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World J Clin Pediatr (2016) 0.75
Multi-Modal Preemptive Analgesia With Pregabalin, Acetaminophen, Naproxen, and Dextromethorphan in Radical Neck Dissection Surgery: A Randomized Clinical Trial. Anesth Pain Med (2016) 0.75
Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial. Exp Ther Med (2016) 0.75
Avoiding Opioids and Their Harmful Side Effects in the Postoperative Patient: Exogenous Opioids, Endogenous Endorphins, Wellness, Mood, and Their Relation to Postoperative Pain. Hawaii J Med Public Health (2016) 0.75
Acetaminophen study yields new insights into neurobiological underpinnings of empathy. J Neurophysiol (2016) 0.75
Acetaminophen use and asthma in children. Can Fam Physician (2017) 0.75
Treatment with analgesics after mouse sciatic nerve injury does not alter expression of wound healing-associated genes. Neural Regen Res (2016) 0.75
Rectal Diclofenac Versus Rectal Paracetamol: Comparison of Antipyretic Effectiveness in Children. Iran Red Crescent Med J (2016) 0.75
Pharmacology: inflammatory definitions. Br Dent J (2014) 0.75
Investigating the application of a nitroreductase-expressing transgenic zebrafish line for high-throughput toxicity testing. Toxicol Rep (2017) 0.75
Paracetamol (acetaminophen): a blessing or a hidden curse? Inflammopharmacology (2013) 0.75
Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus. Eur J Clin Pharmacol (2016) 0.75
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol (1971) 37.53
Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology (2005) 10.66
Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br Med J (1967) 9.40
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) (2012) 9.25
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis (2003) 7.95
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med (2001) 5.96
The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA (1995) 5.05
EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2004) 4.94
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A (2002) 4.80
The comparative safety of analgesics in older adults with arthritis. Arch Intern Med (2010) 4.47
Acetaminophen toxicity in an urban county hospital. N Engl J Med (1997) 4.26
Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest (1994) 4.17
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science (2011) 3.48
Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature (1972) 3.30
Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28
Reye's syndrome in the United States from 1981 through 1997. N Engl J Med (1999) 3.20
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem (2000) 3.19
Effect of pyrogen and antipyretics on prostaglandin acitvity in cisternal c.s.f. of unanaesthetized cats. J Physiol (1973) 3.13
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest (1999) 2.95
Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol (2005) 2.77
A randomised controlled trial of ibuprofen, paracetamol or a combination tablet of ibuprofen/paracetamol in community-derived people with knee pain. Ann Rheum Dis (2011) 2.70
Does paracetamol (acetaminophen) reduce the pain of osteoarthritis? A meta-analysis of randomised controlled trials. Ann Rheum Dis (2004) 2.64
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol (2001) 2.63
Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs. Clin Pharmacol Ther (2006) 2.59
Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum (1993) 2.49
Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem (1997) 2.48
Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ (2004) 2.46
Paracetamol for pain relief after surgical removal of lower wisdom teeth. Cochrane Database Syst Rev (2007) 2.42
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation (2006) 2.26
Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. Am J Respir Crit Care Med (2010) 2.24
Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther (1992) 2.17
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest (2001) 2.16
The management of chronic pain in older persons: AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society. J Am Geriatr Soc (1998) 2.14
Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther (2005) 2.13
Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg (2010) 2.13
Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther (2006) 2.01
Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J (2007) 2.00
Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science (1992) 2.00
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol (2005) 1.95
Mechanism of action of paracetamol. Am J Ther (2005) 1.93
SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN. Arch Int Pharmacodyn Ther (1964) 1.91
Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem (2005) 1.88
Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation (2010) 1.85
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors. Br J Pharmacol (2005) 1.84
Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signal (2008) 1.83
Single dose oral paracetamol (acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev (2008) 1.81
Nonsteroidal antiinflammatory drugs or acetaminophen for osteoarthritis of the hip or knee? A systematic review of evidence and guidelines. J Rheumatol (2004) 1.78
Single dose oral paracetamol (acetaminophen) with codeine for postoperative pain in adults. Cochrane Database Syst Rev (2009) 1.77
Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol (1977) 1.76
Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth (2005) 1.73
Aspirin versus acetaminophen: a comparative view. Pediatrics (1978) 1.71
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review. Br J Anaesth (2011) 1.67
Paracetamol: new vistas of an old drug. CNS Drug Rev (2007) 1.63
Myeloperoxidase in kidney disease. Kidney Int (2003) 1.59
Prostaglandin E2 as a mediator of fever: synthesis and catabolism. Front Biosci (2004) 1.57
Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol (1998) 1.56
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci U S A (2002) 1.55
Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. Can J Clin Pharmacol (2008) 1.55
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci U S A (2002) 1.54
Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal (2009) 1.51
Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest (2009) 1.47
Chronic treatments with aspirin or acetaminophen reduce both the development of polyarthritis and Fos-like immunoreactivity in rat lumbar spinal cord. Pain (1994) 1.46
On the ability of prostaglandin E1, and arachidonic acid to modulate experimentally induced oedema in the rat paw. Br J Pharmacol (1975) 1.45
Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol (2004) 1.44
Further studies on the role of prostaglandin in fever. J Physiol (1974) 1.43
Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery. Br J Anaesth (2005) 1.42
The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci (2001) 1.41
Quantitation of thermography in arthritis using multi-isothermal analysis. II. Effect of nonsteroidal anti-inflammatory therapy on the thermographic index. Ann Rheum Dis (1974) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience (2002) 1.37
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett (1997) 1.36
The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products. Pharmacol Ther (2008) 1.35
Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure. Proc Natl Acad Sci U S A (2010) 1.35
Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol (1976) 1.33
Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J Neurosci (2000) 1.31
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link. QJM (2010) 1.29
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol (2006) 1.27
Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity. Br J Clin Pharmacol (2011) 1.27
Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther (2000) 1.27
New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther (2006) 1.24
Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med (2000) 1.24
Drug combinations and impaired renal function -- the 'triple whammy'. Br J Clin Pharmacol (2005) 1.22
Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta (2006) 1.22
Mechanism of reaction of myeloperoxidase with nitrite. J Biol Chem (2000) 1.21
Paracetamol, alcohol and the liver. Br J Clin Pharmacol (2000) 1.19
Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med (1987) 1.18
Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J (2005) 1.18
Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma. J Allergy Clin Immunol (2010) 1.18
Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol (2008) 1.16
Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr (2010) 1.15
Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther (1997) 1.11
Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain (2008) 1.11
A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol (2002) 1.10
Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am J Physiol Regul Integr Comp Physiol (2010) 1.10
CareTrack: assessing the appropriateness of health care delivery in Australia. Med J Aust (2012) 4.46
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet (2007) 3.58
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis (2013) 2.89
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses. Clin Pharmacol Ther (2005) 2.85
Association of interruptions with an increased risk and severity of medication administration errors. Arch Intern Med (2010) 2.81
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64
Clinical pharmacokinetics of metformin. Clin Pharmacokinet (2011) 2.59
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia. Eur Heart J (2005) 2.52
Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol (2009) 2.44
The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors. Med J Aust (2002) 2.37
Relationship between coronary artery remodeling and plaque vulnerability. Circulation (2002) 2.35
Evaluating medicines: let's use all the evidence. Med J Aust (2007) 2.32
A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interest of patients? Drug Saf (2008) 2.24
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.19
Pethidine in emergency departments: promoting evidence-based prescribing. Med J Aust (2005) 2.18
Does computerized provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc (2009) 2.09
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Death and morbidity from supratherapeutic dosing of colchicine. Med J Aust (2011) 2.02
Mechanism of action of paracetamol. Am J Ther (2005) 1.93
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2007) 1.81
A review of neuraxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital. Anesthesiology (2007) 1.80
Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience. Med J Aust (2005) 1.75
Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update (2004) 1.73
Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes Care (2011) 1.70
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res (2004) 1.65
Subsidised access to TNF alpha inhibitors: is the rationale for exclusion of rheumatoid-factor-negative patients defensible? Med J Aust (2004) 1.65
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord (2010) 1.60
Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol (2004) 1.51
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol (2008) 1.40
Oxidative damage to extracellular matrix and its role in human pathologies. Free Radic Biol Med (2008) 1.40
Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2004) 1.40
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Curr Med Res Opin (2009) 1.39
Utility of urine drug screening: a clinical audit. Emerg Med Australas (2007) 1.39
Quantification of protein modification by oxidants. Free Radic Biol Med (2009) 1.34
Adverse event reporting in clinical trials: room for improvement. Med J Aust (2003) 1.29
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. Curr Med Res Opin (2008) 1.28
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis. BMC Endocr Disord (2008) 1.28
Towards the delivery of appropriate health care in Australia. Med J Aust (2012) 1.27
Dietary composition of pregnant women is related to size of the baby at birth. J Nutr (2004) 1.23
Roles of tyrosine-rich precursor glycoproteins and dityrosine- and 3,4-dihydroxyphenylalanine-mediated protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot Cell (2003) 1.23
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene (2003) 1.23
Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study. BMC Res Notes (2011) 1.22
Effects of two commercial electronic prescribing systems on prescribing error rates in hospital in-patients: a before and after study. PLoS Med (2012) 1.22
Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta (2006) 1.22
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf (2013) 1.22
Oncogenic action of secreted phospholipase A2 in prostate cancer. Cancer Res (2004) 1.21
A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg (2006) 1.20
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Diet around conception and during pregnancy--effects on fetal and neonatal outcomes. Reprod Biomed Online (2006) 1.16
Errors and electronic prescribing: a controlled laboratory study to examine task complexity and interruption effects. J Am Med Inform Assoc (2010) 1.16
Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity. Clin Pharmacol Ther (2006) 1.16
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin (2011) 1.16
Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta (2007) 1.15
Oncogenic action of phospholipase A2 in prostate cancer. Cancer Lett (2005) 1.14
The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab (2002) 1.14
Photo-oxidation of proteins. Photochem Photobiol Sci (2011) 1.14
Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum (2005) 1.12
Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol (2005) 1.11
Failure to utilize functions of an electronic prescribing system and the subsequent generation of 'technically preventable' computerized alerts. J Am Med Inform Assoc (2012) 1.11
Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides. Biochem J (2004) 1.11
Singlet oxygen-mediated protein oxidation: evidence for the formation of reactive side chain peroxides on tyrosine residues. Photochem Photobiol (2002) 1.11
Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod (2002) 1.11
Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate. J Rheumatol (2002) 1.08
Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure? Biochemistry (2007) 1.07
Hypouricemic effects of prednisone and allopurinol: an uneven playing field? Can J Cardiol (2013) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Actions of ultraviolet light on cellular structures. EXS (2006) 1.05
The influence of computerized decision support on prescribing during ward-rounds: are the decision-makers targeted? J Am Med Inform Assoc (2011) 1.05
Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin (2012) 1.02
The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry (2008) 1.02
Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol (2005) 1.01
Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. J Am Coll Cardiol (2006) 1.01
Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer. Clin Cancer Res (2008) 1.01
Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch Biochem Biophys (2003) 1.01
Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin (2012) 1.01
Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol (2002) 1.00
The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines. Aust New Zealand Health Policy (2007) 0.99
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet (2013) 0.99
The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol (2004) 0.99
What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol (2009) 0.99
Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry (2004) 0.99
PACE--the first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial. BMC Musculoskelet Disord (2010) 0.98
Long-term patterns of online evidence retrieval use in general practice: a 12-month study. J Med Internet Res (2008) 0.98
The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem J (2010) 0.98
Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: absolute rate constants and assessment of biological relevance. Biochem J (2009) 0.97
Protein-bound kynurenine is a photosensitizer of oxidative damage. Free Radic Biol Med (2004) 0.97
The safety of electronic prescribing: manifestations, mechanisms, and rates of system-related errors associated with two commercial systems in hospitals. J Am Med Inform Assoc (2013) 0.96
Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem J (2006) 0.96
Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem Res Toxicol (2007) 0.96
Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects. Clin Pharmacokinet (2008) 0.96
Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer. Carcinogenesis (2010) 0.95
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage. Br J Clin Pharmacol (2013) 0.95
Tolerability of paracetamol. Drug Saf (2005) 0.95
Food and nutrient intakes of 9-month-old infants in Adelaide, Australia. Public Health Nutr (2009) 0.95
Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J Am Chem Soc (2003) 0.95
Saving money on the PBS: ranibizumab or bevacizumab for neovascular macular degeneration? Med J Aust (2011) 0.95